Literature DB >> 22203417

Some concerns about the article: "High doses of oxycodone-naloxone combination may provide poor analgesia.".

Christian Compagnone, Fernanda Tagliaferri, Andrea Ramelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22203417     DOI： 10.1007/s00520-011-1346-y

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological treatment of chronic pain - the need for CHANGE.

Authors:  G Varrassi; G Müller-Schwefe; J Pergolizzi; A Orónska; B Morlion; P Mavrocordatos; C Margarit; C Mangas; W Jaksch; F Huygen; B Collett; M Berti; D Aldington; K Ahlbeck
Journal:  Curr Med Res Opin       Date:  2010-05       Impact factor: 2.580

2.  Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised controlled trial.

Authors:  O Löwenstein; P Leyendecker; M Hopp; U Schutter; P D Rogers; R Uhl; S Bond; W Kremers; T Nichols; B Krain; K Reimer
Journal:  Expert Opin Pharmacother       Date:  2009-03       Impact factor: 3.889

3.  Innovative pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: a large observational study under conditions of daily practice.

Authors:  U Schutter; S Grunert; C Meyer; T Schmidt; T Nolte
Journal:  Curr Med Res Opin       Date:  2010-06       Impact factor: 2.580

4.  High doses of oxycodone-naloxone combination may provide poor analgesia.

Authors:  Sebastiano Mercadante; Patrizia Ferrera; Claudio Adile
Journal:  Support Care Cancer       Date:  2011-06-09       Impact factor: 3.603

Review 5.  Role of oxycodone and oxycodone/naloxone in cancer pain management.

Authors:  Wojciech Leppert
Journal:  Pharmacol Rep       Date:  2010 Jul-Aug       Impact factor: 3.024

6.  Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

Authors:  Dana Vondrackova; Petra Leyendecker; Winfried Meissner; Michael Hopp; Istvan Szombati; Kai Hermanns; Christian Ruckes; Susanne Weber; Birgit Grothe; Wolfgang Fleischer; Karen Reimer
Journal:  J Pain       Date:  2008-08-16       Impact factor: 5.820

7.  Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.

Authors:  K Simpson; P Leyendecker; M Hopp; S Müller-Lissner; O Löwenstein; J De Andrés; J Troy Ferrarons; B Bosse; B Krain; T Nichols; W Kremers; K Reimer
Journal:  Curr Med Res Opin       Date:  2008-12       Impact factor: 2.580
  7 in total
  2 in total

Review 1.  New developments in the treatment of opioid-induced gastrointestinal symptoms.

Authors:  Jasper Pannemans; Tim Vanuytsel; Jan Tack
Journal:  United European Gastroenterol J       Date:  2018-08-27       Impact factor: 4.623

2.  Oxycodone/Naloxone: role in chronic pain management, opioid-induced constipation, and abuse deterrence.

Authors:  Anne Z DePriest; Katie Miller
Journal:  Pain Ther       Date:  2014-05-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.